Robert Roswell Chai-Onn, EVP, CLO, General Counsel at Valeant Pharmaceuticals International, Inc. (VRX), sold 90,939 shares at $200.01 ($18.2M) on 2015-03-02, disclosed to the SEC on 2015-03-04.
Scheduled sale ($18.2M) by EVP, CLO, General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| VRX | SELL | 2014-05-14 | $1.3M | — | Filing → |
| VRX | SELL | 2014-03-19 | $709K | — | Filing → |
| VRX | BUY | 2013-08-23 | $500K | — | Filing → |